Varex Imaging Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92214X1063
USD
11.54
0.21 (1.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Varex Imaging Corp. stock-summary
stock-summary
Varex Imaging Corp.
Pharmaceuticals & Biotechnology
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect. The Medical business segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, radiation therapy and computer-aided detection. The Industrial business segment designs, manufactures, sells and services products for use in security and industrial inspection applications, such as cargo screening at ports and borders and non-destructive examination in a range of applications.
Company Coordinates stock-summary
Company Details
1678 S Pioneer Rd , SALT LAKE CITY UT : 84104-4205
stock-summary
Tel: 1 801 97250001 801 9785274
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 63 Schemes (58.56%)

Foreign Institutions

Held by 97 Foreign Institutions (7.54%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Ruediger Naumann-Etienne
Independent Chairman of the Board
Mr. Sunny Sanyal
President, Chief Executive Officer, Director
Dr. Jocelyn Chertoff
Independent Director
Mr. Timothy Guertin
Independent Director
Mr. Jay Kunkel
Independent Director
Mr. Walter Rosebrough
Independent Director
Ms. Christine Tsingos
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
203 Million
(Quarterly Results - Jun 2025)
Net Profit:
-89 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 484 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.48

stock-summary
Return on Equity

-8.53%

stock-summary
Price to Book

1.06